Skip to content
PatentBrief
Get alertsTop ↑

How Constantin Fahlberg Discovered Saccharin

The 1885 patent for the chemical process to create saccharin, the first artificial sweetener, discovered by accident in a coal tar laboratory.

Granted 1885ActiveOwned by Constantin Fahlberg

Original patent title: “Coxstaintix fahlberg

Plain-English explanation by SahiLast reviewed · June 13, 2026

The 1885 patent for the chemical process to create saccharin, the first artificial sweetener, discovered by accident in a coal tar laboratory. Granted to Constantin Fahlberg in 1885 with 3 forward citations.

Key facts

Patent numberUS 319082
StatusActive
FieldBiotech & Medicine
AssigneeConstantin Fahlberg
Granted1885
Times cited3
LitigationNone on record
Value · $9K$29KMinimal

Coverage

What does this patent actually cover?

This patent describes the chemical synthesis of benzoic sulfimide, commonly known as saccharin. It details the process of converting toluene into ortho-toluenesulfonamide, which is then oxidized to produce the final sweetener. The mechanism relies on specific chemical reactions to isolate the sweet-tasting compound from coal tar derivatives. It effectively allowed for the mass production of a sugar substitute that is hundreds of times sweeter than sucrose.

The gap

What does this patent NOT cover?

  • Does not cover natural sweeteners like honey or stevia.
  • Does not cover other artificial sweeteners discovered later, such as aspartame or sucralose.
  • Does not cover the health implications or metabolic effects of consuming saccharin.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

Fahlberg noticed a sweet taste on his hands after working with coal tar derivatives in the lab, realizing that one of his chemical experiments had inadvertently produced a substance of extreme sweetness.

Coxstaintix fahlberg(Primary claim)biotechchemical manufacturing

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Sweet'N Low packets

02

Diet sodas from the mid-20th century

03

Sugar-free chewing gum

Why it matters

The bigger picture

This patent marks the birth of the artificial sweetener industry. It provided a viable alternative to sugar during times of scarcity and for individuals with medical conditions like diabetes, fundamentally changing food manufacturing and dietary habits in the 20th century.

Granted

June 2, 1885

Market context

Who's building on this

Companies in this space

The original patent has long expired, allowing companies like Cumberland Packing Corp to dominate the market with brands like Sweet'N Low. Modern food science companies continue to build on this by creating newer, non-bitter synthetic sweeteners.

Market impact

This patent created the entire category of high-intensity artificial sweeteners. It triggered early 20th-century debates about food purity and regulation, eventually leading to the establishment of strict food additive testing protocols.

Claim 1 — Plain English

What this patent covers

This patent describes the chemical synthesis of benzoic sulfimide, commonly known as saccharin. It details the process of converting toluene into ortho-toluenesulfonamide, which is then oxidized to produce the final sweetener. The mechanism relies on specific chemical reactions to isolate the sweet-tasting compound from coal tar derivatives. It effectively allowed for the mass production of a sugar substitute that is hundreds of times sweeter than sucrose.

The clever bit

Fahlberg noticed a sweet taste on his hands after working with coal tar derivatives in the lab, realizing that one of his chemical experiments had inadvertently produced a substance of extreme sweetness.

What it does not cover

  • Does not cover natural sweeteners like honey or stevia.
  • Does not cover other artificial sweeteners discovered later, such as aspartame or sucralose.
  • Does not cover the health implications or metabolic effects of consuming saccharin.

PatentBrief Score

Impact Score

Limited data

Citation count

12/40

Early citations

Claim breadth

0/20

Narrow claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

0/20

Older than 20 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Minimal

$9K$29K

Midpoint $18K · expired or expiring · industry ×3.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cited by later patents

3

later patents that build on this invention

View patents →

Cite this patent

(1885). How Constantin Fahlberg Discovered Saccharin (U.S. Patent No. 319,082). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/319082/saccharin-artificial-sweetener-fahlberg

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US319082"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4405829 · 1983

How RSA Public-Key Encryption Keeps Digital Messages Secret

This patent describes the foundational RSA algorithm, a method for securely sending messages where anyone can encrypt a message using a public key, but only the intended recipient can decrypt it using a secret private key.

Massachusetts Institute of Technology

US 4575330 · 1986

How 3D Printers Build Objects Layer by Layer from Liquid

This patent describes the foundational method for 3D printing, where a machine builds a three-dimensional object layer by layer by hardening a liquid material with light or other energy.

UVP Inc

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary

Common Questions

Frequently Asked Questions

What does How Constantin Fahlberg Discovered Saccharin cover?

The 1885 patent for the chemical process to create saccharin, the first artificial sweetener, discovered by accident in a coal tar laboratory.

Who owns patent US 319082?

Constantin Fahlberg owns this patent, granted in 1885.

When does this patent expire?

This patent has expired and is now in the public domain — anyone can use the invention freely.

What is patent US 319082 cited by?

This patent has been cited by 3 later patents that build on its ideas.

What problem does this patent solve?

This patent marks the birth of the artificial sweetener industry. It provided a viable alternative to sugar during times of scarcity and for individuals with medical conditions like diabetes, fundamentally changing food manufacturing and dietary habits in the 20th century.

What does this patent NOT cover?

Does not cover natural sweeteners like honey or stevia.

Patent monitoring

Get notified when Constantin Fahlberg files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: June 13, 2026 · PatentBrief is not a law firm and this is not legal advice.